Comparison of Insulin, Sulfonylurea and Sulfonylureas-Metformin Combination on HbA1c and eGFR Level on Age-, Sex- and BMI-Matched Groups of Indonesian Type 2 DM Patients
1, 1★, 1★ Corresponding author
- 1Faculty of Pharmacy, Universitas Indonesia, Depok, INDONESIA.
CORRESPONDENCE
Rani Sauriasari
Faculty of Pharmacy, Universitas Indonesia, Depok, INDONESIA.
Received: 14-04-2018; Revised: 02-05-2018; Accepted: 27-07-2018.
Volume 10, Issue 4 · pp. 471-475 · 2018 · DOI: 10.5530/jyp.2018.10.102
ABSTRACT
Objective: This study aimed to evaluate efficacy of insulin, sulfonylurea, and sulfonylureas-metformin combination in reducing the HbA1c level and preventing renal function decline in type 2 diabetes mellitus (DM) patients in Indonesia.Methods: A cross-sectional study was conducted at Dr. Sitanala Hospital involving 105 patients who were taking: insulin (30), sulfonylureas (30) and sulfonylureas-metformin combination (45). The subjects were classified into age-, sex- and BMI-matched groups. We measured their HbA1c level and serum creatinine to calculate eGFR level.Results: There were no differences among the three groups in term of age, sex, BMI, occupation and exercise habit. However, diet and family history of DM were different between the three groups. The average of HbA1c levels in the sulfonylureas-metformin group was 7.46±1.81 and showed a significant difference compared to the insulin group (8.27±1.74) with p=0.042. No significant difference existed in eGFR in the three groups (p=0.476). Subjects with obesity or BMI >30 kg/m2 had 3.268 times probability (p= 0.001) of having HbA1c >7 relative to underweight (BMI 7%, compared to those without diabetic family history (p = 0.002).Conclusion: We found in this study site that sulfonylureas-metformin combination was more efficient in decreasing HbA1c level in type 2 DM patients compared to insulin or sulfonylureas monotherapy. Family history of DM and overweight had considerable effect on uncontrolled HbA1c. Meanwhile, there was no significant difference among the three groups in preventing the decline of eGFR.
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Sylvia, S., Sauriasari, R., & Andrajati, R. (2018). Comparison of Insulin, Sulfonylurea and Sulfonylureas-Metformin Combination on HbA1c and eGFR Level on Age-, Sex- and BMI-Matched Groups of Indonesian Type 2 DM Patients. Journal of Young Pharmacists, 10(4), 471-475. https://doi.org/10.5530/jyp.2018.10.102
Copyright and licence
© 2018 Author(s)
This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. CC BY-NC-SA 4.0
